News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Turka Laurence A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2022 |
4
| Turka Laurence A. (Chief Scientific Officer) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Sold 2,517 shares
@ $6.573, valued at
$16.5k
Exercised 7,438 restricted stock units
@ $0
Granted 143,750 options to buy
@ $6.75, valued at
$970.3k
Granted 34,500 restricted stock units
@ $0 |
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2020 |
4
| Turka Laurence A. (Chief Scientific Officer) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 350,000 options to buy
@ $7.8, valued at
$2.7M
|
|
| 01/28/2020 |
3
| Turka Laurence A. (Chief Scientific Officer) has filed a Form 3 on Rubius Therapeutics, Inc. |
|
|